Article Versions Notes

Chou M-H, Chuang H-C, Lin Y-T, Tsai M-H, Kao Y-H, Lin I-C, Huang T-L, Fang F-M, Chien C-Y. Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2021; 22(6):3046. https://doi.org/10.3390/ijms22063046

Chou, Ming-Huei, Hui-Ching Chuang, Yu-Tsai Lin, Ming-Hsien Tsai, Ying-Hsien Kao, I-Chun Lin, Tai-Lin Huang, Fu-Min Fang, and Chih-Yen Chien. 2021. "Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma" International Journal of Molecular Sciences 22, no. 6: 3046. https://doi.org/10.3390/ijms22063046

Chou, M.-H., Chuang, H.-C., Lin, Y.-T., Tsai, M.-H., Kao, Y.-H., Lin, I.-C., Huang, T.-L., Fang, F.-M., & Chien, C.-Y. (2021). Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 22(6), 3046. https://doi.org/10.3390/ijms22063046